Low-dose anticoagulant OK with aortic valve replacement

05/13/2013 | PhysiciansBriefing.com

Patients needing aortic valve replacement who were administered with lower-dose warfarin following implantation were at reduced risk for major and minor bleeding compared with those given the standard-dose anticoagulant therapy, according to findings presented at a thoracic surgery meeting. "In combination with low-dose aspirin, this therapy resulted in significantly lower risk of bleeding than customary aggressive anticoagulation, without significant increase in clots or strokes," said Dr. John D. Puskas of Emory University.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA